Wnt signaling in the vasculature

Angiogenesis

Volumn 5, Issue 1-2, 2002, Pages 1-9

  Goodwin, A M ^a   D'Amore, P A ^a  

^a SCHEPENS EYE RESEARCH INSTITUTE   (United States)

Author keywords

catenin; Angiogenesis; Endostatin; Frizzled; Frizzled related protein; Intimal hyperplasia

Indexed keywords

BETA CATENIN; FRIZZLED PROTEIN; FRIZZLED RELATED PROTEIN; FRIZZLED RELATED PROTEIN 1; FRIZZLED RELATED PROTEIN 3; PROTEIN FZ1; PROTEIN FZ2; PROTEIN FZ3; PROTEIN WNT10B; PROTEIN WNT7A; RECEPTOR PROTEIN; UNCLASSIFIED DRUG; WNT PROTEIN; WNT2 PROTEIN; WNT5A PROTEIN;

ANIMAL CELL; CARCINOGENESIS; EMBRYO CELL; LETHAL MUTANT; LIGAND BINDING; MOUSE; NONHUMAN; OBSERVATION; PATHOPHYSIOLOGY; PLACENTA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN STABILITY; REVIEW; SIGNAL TRANSDUCTION; VASCULARIZATION;

ANIMALS; BETA CATENIN; BLOOD VESSELS; COLLAGEN; CYTOSKELETAL PROTEINS; ENDOSTATINS; HUMANS; PEPTIDE FRAGMENTS; PROTO-ONCOGENE PROTEINS; SIGNAL TRANSDUCTION; TRANS-ACTIVATORS; WNT PROTEINS; WNT2 PROTEIN; ZEBRAFISH PROTEINS;

ANIMALIA; MURINAE;

EID: 0036937945     PISSN: 09696970     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1021563510866     Document Type: Review

References (103)

1. Orsulic S, Peifer M. Cell-cell signalling: Wingless lands at last. Curr Biol 1996; 6: 1363-7.
2. Dale TC. Signal transduction by the Wnt family of ligands. Biochem J 1998; 329: 209-23.
3. Miller JR. The Wnts. Genome Biol 2001; 3: 1-15.
4. Moon RT, Brown JD, Yang-Snyder JA, Miller JR. Structurally related receptors and antagonists compete for secreted Wnt ligands. Cell 1997; 88: 725-8.
5. Zorn AM. Wnt signalling: Antagonistic Dickkopfs. Curr Biol 2001; 11: R592-5.
6. Hsieh JC, Kodjabachian L, Rebbert ML et al. A new secreted protein that binds to Wnt proteins and inhibits their activities. Nature 1999; 398: 431-6.
7. Piccolo S, Agius E, Leyns L et al. The head inducer Cerberus is a multifunctional antagonist of Nodal, BMP and Wnt signals. Nature 1999; 397: 707-10.
8. Uusitalo M, Heikkila M, Vainio S. Molecular genetic studies of Wnt signaling in the mouse. Exp Cell Res 1999; 253: 336-48.
9. Schneider VA, Mercola M. Wnt antagonism initiates cardiogenesis in Xenopus laevis. Genes Dev 2001; 15: 304-15.
10. Marvin MJ, Di Rocco G, Gardiner A et al. Inhibition of Wnt activity induces heart formation from posterior mesoderm. Genes Dev 2001; 15: 316-27.
11. Pandur P, Läsche M, Eisenberg LM, Kühl M. Wnt-11 activation of a non-canonical Wnt signalling pathway is required for cardiogenesis. Nature 2002; 418: 636-41.
12. Van Den Berg DJ, Sharma AK, Bruno E, Hoffman R. Role of members of the Wnt gene family in human hematopoiesis. Blood 1998; 92: 3189-202.
13. Brandon C, Eisenberg LM, Eisenberg CA. WNT signaling modulates the diversification of hematopoietic cells. Blood 2000; 96: 4132-41.
14. Yamane T, Kunisada T, Tsukamoto H et al. Wnt signaling regulates hemopoiesis through stromal cells. J Immunol 2001; 167: 765-72.
15. Morin PJ. Beta-catenin signaling and cancer. Bioessays 1999; 21: 1021-30.
16. Polakis P. Wnt signaling and cancer. Genes Dev 2000; 14: 1837-51.
17. Smalley MJ, Dale TC. Wnt signalling in mammalian development and cancer. Cancer Metastasis Rev 1999; 18: 215-30.
18. Sen M, Lauterbach K, El-Gabalawy H et al. Expression and function of wingless and frizzled homologs in rheumatoid arthritis. Proc Natl Acad Sci USA 2000; 97: 2791-6.
19. Sen M, Chamorro M, Reifert J et al. Blockade of Wnt-5A/frizzled 5 signaling inhibits rheumatoid synoviocyte activation. Arthritis Rheum 2001; 44: 772-81.
20. De Ferrari GV, Inestrosa NC. Wnt signaling function in Alzheimer's disease. Brain Res Brain Res Rev 2000; 33: 1-12.
21. Darland DC, D'Amore PA. Cell-cell interactions in vascular development. Curr Top Dev Biol 2001; 52: 107-49.
22. Dimmeler S, Zeiher AM. Endothelial cell apoptosis in angiogenesis and vessel regression. Circ Res 2000; 87: 434-9.
23. Nör JE, Polverini PJ. Role of endothelial cell survival and death signals in angiogenesis. Angiogenesis 1999; 3: 101-16.
24. Fisher SA, Langille BL, Srivastava D. Apoptosis during cardiovascular development. Circ Res 2000; 87: 856-64.
25. Folkman J. Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat Med 1995; 1: 27-31.
26. Newby AC, Zaltsman AB. Molecular mechanisms in intimal hyperplasia. J Pathol 2000; 190: 300-9.
27. Wright M, Aikawa M, Szeto W, Papkoff J. Identification of a Wnt-responsive signal transduction pathway in primary endothelial cells. Biochem Biophys Res Commun 1999; 263: 384-8.
28. Monkley SJ, Delaney SJ, Pennisi DJ et al. Targeted disruption of the Wnt2 gene results in placentation defects. Development 1996; 122: 3343-53.
29. Ishikawa T, Tamai Y, Zorn AM et al. Mouse Wnt receptor gene Fzd5 is essential for yolk sac and placental angiogenesis. Development 2001; 128: 25-33.
30. Chen S, Guttridge DC, You Z et al. Wnt-1 signaling inhibits apoptosis by activating beta-catenin/T cell factor-mediated transcription. J Cell Biol 2001; 152: 87-96.
31. Mao C, Malek OT, Pueyo ME et al. Differential expression of rat frizzled-related frzb-1 and frizzled receptor fz1 and fz2 genes in the rat aorta after balloon injury. Arterioscler Thromb Vasc Biol 2000; 20: 43-51.
32. Sala CF, Formenti E, Terstappen GC, Caricasole A. Identification, gene structure, and expression of human frizzled-3 (FZD3). Biochem Biophys Res Commun 2000; 273: 27-34.
33. Chan SD, Karpf DB, Fowlkes ME et al. Two homologs of the Drosophila polarity gene frizzled (fz) are widely expressed in mammalian tissues. J Biol Chem 1992; 267: 25202-7.
34. van Gijn ME, Blankesteijn WM, Smits JF et al. Frizzled 2 is transiently expressed in neural crest-containing areas during development of the heart and great arteries in the mouse. Anat Embryol (Berl) 2001; 203: 185-92.
35. Blankesteijn WM, Essers-Janssen YP, Verluyten MJ et al. A homologue of Drosophila tissue polarity gene frizzled is expressed in migrating myofibroblasts in the infarcted rat heart. Nat Med 1997; 3: 541-4.
36. Gazit A, Yaniv A, Bafico A et al. Human frizzled 1 interacts with transforming Wnts to transduce a TCF dependent transcriptional response. Oncogene 1999; 18: 5959-66.
37. He X, Saint-Jeannet JP, Wang Y et al. A member of the Frizzled protein family mediating axis induction by Wnt-5A. Science 1997; 275: 1652-4.
38. Wang Y, Huso D, Cahill H et al. Progressive cerebellar, auditory, and esophageal dysfunction caused by targeted disruption of the frizzled-4 gene. J Neurosci 2001; 21: 461-71.
39. Robitaille J, MacDonald ML, Kaykas A et al. Mutant frizzled-4 disrupts retinal angiogenesis in familial exudative vitreoretinopathy. Nat Genet (in press).
40. Jaspard B, Couffinhal T, Dufourcq P et al. Expression pattern of mouse sFRP-1 and mWnt-8 gene during heart morphogenesis. Mech Dev 2000; 90: 263-7.
41. Duplàa C, Jaspard B, Moreau C, D'Amore PA. Identification and cloning of a secreted protein related to the cysteine-rich domain of frizzled: Evidence for a role in endothelial cell growth control. Circ Res 1999; 84: 1433-45.
42. Dennis S, Aikawa M, Szeto W et al. A secreted frizzled related protein, FrzA, selectively associates with Wnt-1 protein and regulates Wnt-1 signaling. J Cell Sci 1999; 112: 3815-20.
43. Bafico A, Gazit A, Pramila T et al. Interaction of frizzled related protein (FRP) with Wnt ligands and the frizzled receptor suggests alternative mechanisms for FRP inhibition of Wnt signaling. J Biol Chem 1999; 274: 16180-7.
44. Finch PW, He X, Kelley MJ et al. Purification and molecular cloning of a secreted, Frizzled-related antagonist of Wnt action. Proc Natl Acad Sci USA 1997; 94: 6770-5.
45. Xu Q, D'Amore PA, Sokol SY. Functional and biochemical interactions of Wnts with FrzA, a secreted Wnt antagonist. Development 1998; 125: 4767-76.
46. Melkonyan HS, Chang WC, Shapiro JP et al. SARPs: A family of secreted apoptosis-related proteins. Proc Natl Acad Sci USA 1997; 94: 13636-41.
47. Mayr T, Deutsch U, Kuhl M et al. Fritz: A secreted frizzled-related protein that inhibits Wnt activity. Mech Dev 1997; 63: 109-25.
48. Schumann H, Holtz J, Zerkowski HR, Hatzfeld M. Expression of secreted frizzled related proteins 3 and 4 in human ventricular myocardium correlates with apoptosis related gene expression. Cardiovasc Res 2000; 45: 720-8.
49. Wang S, Krinks M, Lin K et al. Frzb, a secreted protein expressed in the Spemann organizer, binds and inhibits Wnt-8. Cell 1997; 88: 757-66.
50. Wang S, Krinks M, Moos M Jr. Frzb-1, an antagonist of Wnt-1 and Wnt-8, does not block signaling by Wnts -3A, -5A, or -11. Biochem Biophys Res Commun 1997; 236: 502-4.
51. Eberhart CG, Tihan T, Burger PC. Nuclear localization and mutation of beta-catenin in medulloblastomas. J Neuropathol Exp Neurol 2000; 59: 333-7.
52. Eberhart CG, Argani P. Wnt signaling in human development: Beta-catenin nuclear translocation in fetal lung, kidney, placenta, capillaries, adrenal, and cartilage. Pediatr Dev Pathol 2001; 4: 351-7.
53. Blankesteijn WM, van Gijn ME, Essers-Janssen YP et al. Beta-catenin, an inducer of uncontrolled cell proliferation and migration in malignancies, is localized in the cytoplasm of vascular endothelium during neovascularization after myocardial infarction. Am J Pathol 2000; 157: 877-83.
54. Yano H, Hara A, Shinoda J et al. Immunohistochemical analysis of beta-catenin in N-ethyl-N-nitrosourea-induced rat gliomas: Implications in regulation of angiogenesis. Neurol Res 2000; 22: 527-32.
55. Yano H, Hara A, Takenaka K et al. Differential expression of beta-catenin in human glioblastoma multiforme and normal brain tissue. Neurol Res 2000; 22: 650-6.
56. Wang X, Xiao Y, Mou Y et al. A role for the beta-catenin/T-cell factor signaling cascade in vascular remodeling. Circ Res 2002; 90: 340-7.
57. van der Heyden MA, Rook MB, Hermans MM et al. Identification of connexin43 as a functional target for Wnt signalling. J Cell Sci 1998; 111: 1741-9.
58. Ai Z, Fischer A, Spray DC et al. Wnt-1 regulation of connexin43 in cardiac myocytes. J Clin Invest 2000; 105: 161-71.
59. Kwak BR, Pepper MS, Gros DB, Meda P. Inhibition of endothelial wound repair by dominant negative connexin inhibitors. Mol Biol Cell 2001; 12: 831-45.
60. Gabriels JE, Paul DL. Connexin43 is highly localized to sites of disturbed flow in rat aortic endothelium but connexin37 and connexin40 are more uniformly distributed. Circ Res 1998; 83: 636-43.
61. Yeh HI, Lai YJ, Chang HM et al. Multiple connexin expression in regenerating arterial endothelial gap junctions. Arterioscler Thromb Vasc Biol 2000; 20: 1753-62.
62. Moses MA. The regulation of neovascularization of matrix metalloproteinases and their inhibitors. Stem Cells 1997; 15: 180-9.
63. Brabletz T, Jung A, Dag S et al. Beta-catenin regulates the expression of the matrix metalloproteinase-7 in human colorectal cancer. Am J Pathol 1999; 155: 1033-8.
64. Crawford HC, Fingleton BM, Rudolph-Owen LA et al. The metalloproteinase matrilysin is a target of beta-catenin transactivation in intestinal tumors. Oncogene 1999; 18: 2883-91.
65. Huo N, Ichikawa Y, Kamiyama M et al. MMP-7 (matrilysin) accelerated growth of human umbilical vein endothelial cells. Cancer Lett 2002; 177: 95-100.
66. Gradl D, Kuhl M, Wedlich D. The Wnt/Wg signal transducer β-catenin controls fibronectin expression. Mol Cell Biol 1999; 19: 5576-87.
67. Thyberg J, Blomgren K, Roy J, Tran PK, Hedin U. Phenotypic modulation of smooth muscle cells after arterial injury is associated with changes in the distribution of laminin and fibronectin. J Histochem Cytochem 1997; 45: 837-46.
68. Roy J, Tran PK, Religa P et al. Fibronectin promotes cell cycle entry in smooth muscle cells in primary culture. Exp Cell Res 2002; 273: 169-77.
69. Roberts JM. Evolving ideas about cyclins. Cell 1999; 98: 129-32.
70. Tetsu O, McCormick F. Beta-catenin regulates expression of cyclin D1 in colon carcinoma cells. Nature 1999; 398: 422-6.
71. Shtutman M, Zhurinsky J, Simcha I et al. The cyclin D1 gene is a target of the beta-catenin/LEF-1 pathway. Proc Natl Acad Sci USA 1999; 96: 5522-7.
72. He TC, Sparks AB, Rago C et al. Identification of c-MYC as a target of the APC pathway. Science 1998; 281: 1509-12.
73. Hilker M, Tellmann G, Buerke M et al. Expression of the protooncogene c-myc in human stenotic aortocoronary bypass grafts. Pathol Res Pract 2001; 197: 811-6.
74. Ngo CV, Gee M, Akhtar N et al. An in vivo function for the transforming Myc protein: Elicitation of the angiogenic phenotype. Cell Growth Differ 2000; 11: 201-10.
75. Howe LR, Subbaramaiah K, Chung WJ et al. Transcriptional activation of cyclooxygenase-2 in Wnt-1-transformed mouse mammary epithelial cells. Cancer Res 1999; 59: 1572-7.
76. Gately S. The contributions of cyclooxygenase-2 to tumor angiogenesis. Cancer Metastasis Rev 2000; 19: 19-27.
77. Zhang X, Gaspard JP, Chung DC. Regulation of vascular endothelial growth factor by the Wnt and k-ras pathways in colonic neoplasia. Cancer Res 2001; 61: 6050-4.
78. Ferrara N. Role of vascular endothelial growth factor in regulation of physiological angiogenesis. Am J Physiol Cell Physiol 2001; 280: C1358-66.
79. 2+ pathway: A new vertebrate Wnt signaling pathway takes shape. Trends Genet 2000; 16: 279-83.
80. Boutros M, Mlodzik M. Dishevelled: At the crossroads of divergent intracellular signaling pathways. Mech Dev 1999; 83: 27-37.
81. Weston CR, Davis RJ. The JNK signal transduction pathway. Curr Opin Genet Dev 2002; 12: 14-21.
82. Cossu G, Borello U. Wnt signaling and the activation of myogenesis in mammals. EMBO J 1999; 18: 6867-72.
83. Kwan H, Pecenka V, Tsukamoto A et al. Transgenes expressing the Wnt-1 and int-2 proto-oncogenes cooperate during mammary carcinogenesis in doubly transgenic mice. Mol Cell Biol 1992; 12: 147-54.
84. Capdevila J, Izpisua Belmonte JC. Patterning mechanisms controlling vertebrate limb development. Annu Rev Cell Dev Biol 2001; 17: 87-132.
85. Manoukian AS, Woodgett JR. Role of glycogen synthase kinase-3 in cancer: Regulation by Wnts and other signaling pathways. Adv Cancer Res 2002; 84: 203-29.
86. Conacci-Sorrell M, Zhurinsky J, Ben-Ze'ev A. The cadherincatenin adhesion system in signaling and cancer. J Clin Invest 2002; 109: 987-91.
87. Stambolic V. PTEN: A new twist on beta-catenin? Trends Pharmacol Sci 2002; 23: 104-6.
88. Labbé E, Letamendia A, Attisano L. Association of Smads with lymphoid enhancer binding factor 1/T cell-specific factor mediates cooperative signaling by the transforming growth factor-beta and Wnt pathways. Proc Natl Acad Sci USA 2000; 97: 8358-63.
89. Letamendia A, Labbé E, Attisano L. Transcriptional regulation by Smads: crosstalk between the TGF-beta and Wnt pathways. J Bone Joint Surg Am 2001; 83-A: S31-9.
90. Nishita M, Hashimoto MK, Ogata S et al. Interaction between Wnt and TGF-beta signalling pathways during formation of Spemann's organizer. Nature 2000; 403: 781-5.
91. Smalley MJ, Dale TC. Wnt signaling and mammary tumorigenesis. J Mammary Gland Biol Neoplasia 2001; 6: 37-52.
92. Vainio SJ, Uusitalo MS. A road to kidney tubules via the Wnt pathway. Pediatr Nephrol 2000; 15: 151-6.
93. Lin Y, Liu A, Zhang S et al. Induction of ureter branching as a response to Wnt-2b signaling during early kidney organogenesis. Dev Dyn 2001; 222: 26-39.
94. Uyttendaele H, Soriano JV, Montesano R, Kitajewski J. Notch4 and Wnt-1 proteins function to regulate branching morphogenesis of mammary epithelial cells in an opposing fashion. Dev Biol 1998; 196: 204-17.
95. Leong KG, Hu X, Li L et al. Activated Notch4 inhibits angiogenesis: Role of beta 1-integrin activation. Mol Cell Biol 2002; 22: 2830-41.
96. O'Reilly M, Boehm T, Shing Y et al. Endostatin: An endogenous inhibitor of angiogenesis and tumor growth. Cell 1997; 88: 277-5.
97. Sim BK, MacDonald NJ, Gubish ER. Angiostatin and endostatin: Endogenous inhibitors of tumor growth. Cancer Metastasis Rev 2000; 19: 181-90.
98. Shichiri M, Hirata Y. Antiangiogenesis signals by endostatin. FASEB J 2001; 15: 1044-153.
99. Hanai JI, Dhanabal M, Karumanchi SA et al. Endostatin causes G1 arrest of endothelial cells through inhibition of Cyclin D1. J Biol Chem 2002; 277: 16464-9.
100. Hanai JI, Gloy J, Karumanchi SA et al. Endostatin is a potential inhibitor of Wnt signaling. J Cell Biol 2002; 158: 529-39.
101. Venkiteswaran K, Xiao K, Summers S et al. Regulation of endothelial barrier function and growth by VE-cadherin, plakoglobin, and beta-catenin. Am J Physiol Cell Physiol 2002; 283: C811-21.
102. Shu W, Jiang YQ, Lu MM, Morrisey EE. Wnt7b regulates mesenchymal proliferation and vascular development in the lung. Development 2002; 129: 4831-42.
103. Parr BA, Cornish VA, Cybulsky MI, McMahon AP. Wnt7b regulates placental development in mice. Dev Biol 2001; 237: 324-32.